Independent effect of cardiometabolic syndromes and depression on dementia in Parkinson's disease: A 12‐year longitudinal follow‐up study of a nationwide cohort

We aimed to investigate the incidence rate of Parkinson's disease dementia (PDD) according to age and disease duration by sex. Furthermore, we explored the effect of each cardiometabolic syndrome and depression on the incidence of PDD.

[1]  Jun Pyo Kim,et al.  Cortical neuroanatomical changes related to specific neuropsychological deficits in subcortical vascular cognitive impairment , 2021, NeuroImage: Clinical.

[2]  R. Monastero,et al.  Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study , 2020, Journal of Neurology.

[3]  P. Matthews,et al.  Associations of Regional Brain Structural Differences With Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance , 2019, JAMA network open.

[4]  K. Wyman-Chick,et al.  Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson's Disease. , 2019, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[5]  Brian A. Gordon,et al.  Assessment of Racial Disparities in Biomarkers for Alzheimer Disease , 2019, JAMA neurology.

[6]  M. Jeong,et al.  Current status of acute myocardial infarction in Korea , 2018, The Korean journal of internal medicine.

[7]  D. Mungas,et al.  Progress and future challenges in aging and diversity research in the United States , 2018, Alzheimer's & Dementia.

[8]  S. Studenski,et al.  Metabolic Syndrome and Amyloid Accumulation in the Aging Brain. , 2018, Journal of Alzheimer's disease : JAD.

[9]  W. Rocca,et al.  Parkinson disease with and without Dementia: A prevalence study and future projections , 2018, Movement disorders : official journal of the Movement Disorder Society.

[10]  N. Dupré,et al.  The influence of vascular risk factors on cognitive function in early Parkinson's disease , 2018, International journal of geriatric psychiatry.

[11]  N. Kandiah,et al.  Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease , 2017, Journal of the Neurological Sciences.

[12]  A. Rahmim,et al.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.

[13]  Y. Shim,et al.  Prevalence and treatment pattern of Parkinson's disease dementia in Korea , 2016, Geriatrics & gerontology international.

[14]  J. Trojanowski,et al.  Longitudinal study of normal cognition in Parkinson disease , 2015, Neurology.

[15]  A. Venneri,et al.  Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review , 2015, Journal of the Neurological Sciences.

[16]  N. Kandiah,et al.  Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function. , 2015, Parkinsonism & related disorders.

[17]  W. Jagust,et al.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. , 2015, The journal of prevention of Alzheimer's disease.

[18]  R. Albin,et al.  Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. , 2014, Parkinsonism & related disorders.

[19]  D. Moser,et al.  Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients , 2014, European journal of neurology.

[20]  I. Rosset,et al.  Global Epidemiology of Dementia: Alzheimer's and Vascular Types , 2014, BioMed research international.

[21]  T. Ninomiya,et al.  Diabetes Mellitus and Dementia , 2014, Current Diabetes Reports.

[22]  K. Jellinger.  Pathology and pathogenesis of vascular cognitive impairment—a critical update , 2013, Front. Aging Neurosci..

[23]  Constantinos Kallis,et al.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? , 2011, Brain : a journal of neurology.

[24]  M Filippi,et al.  Regional patterns of brain tissue loss associated with depression in Parkinson disease , 2010, Neurology.

[25]  D. Berg,et al.  Progression of Parkinson's disease in the clinical phase: potential markers , 2009, The Lancet Neurology.

[26]  D. Y. Lee,et al.  Prevalence of Dementia and Its Subtypes in an Elderly Urban Korean Population: Results from the Korean Longitudinal Study on Health and Aging (KLoSHA) , 2008, Dementia and Geriatric Cognitive Disorders.

[27]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[28]  A. Hout,et al.  Dementia and survival in Parkinson disease , 2008, Neurology.

[29]  Z. Illés,et al.  Morphometric changes of gray matter in Parkinson's disease with depression: A voxel‐based morphometry study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[30]  R. Whitmer.  Type 2 diabetes and risk of cognitive impairment and dementia , 2007, Current neurology and neuroscience reports.

[31]  Ho-Young Son,et al.  Epidemic obesity and type 2 diabetes in Asia , 2006, The Lancet.

[32]  T. Erkinjuntti,et al.  Small Vessel Disease and Subcortical Vascular Dementia , 2006, Journal of clinical neurology.

[33]  D. Aarsland,et al.  A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[34]  Gérard Waeber,et al.  Geriatric depression and vascular diseases: what are the links? , 2004, Journal of affective disorders.

[35]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[36]  G. Alexopoulos.  "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? , 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[37]  S. Black,et al.  Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD , 2001 .

[38]  G. Glosser,et al.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.

[39]  Yaakov Stern,et al.  Dementia in Parkinson's disease , 1994, Neurology.

[40]  Y. Agid,et al.  Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. , 1993, Archives of neurology.

[41]  D. Berg,et al.  Vascular Risk Factors and Cognition in Parkinson's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[42]  Junyan Wu,et al.  Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity. , 2014, Functional neurology.

[43]  G. Jicha,et al.  Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. , 2010, Journal of Alzheimer's disease : JAD.